Patents by Inventor Tamaz Omarovich Manasherov
Tamaz Omarovich Manasherov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11213492Abstract: Colloidal antiseptic compositions for treating wounds and/or for use in surgical operations are provided. The compositions form an elastic air- and water-permeable biodegradable film on the wound surface and have antiseptic, hemostatic, anti-inflammatory, wound-healing, and especially anesthetic and antitoxic effects. The compositions include a collagen hydrolysate, one or more salts of alginic acid and one or more antiseptics, and additionally include unithiol and dimethylsulfoxide. The compositions may also optionally include one or more anesthetics.Type: GrantFiled: December 5, 2017Date of Patent: January 4, 2022Assignee: MEDID INNOVATION DEVELOPMENT LTDInventors: Gennady Evgenievich Afinogenov, Tamaz Omarovich Manasherov, Svetlana Konstantinovna Matelo, Anna Gennadievna Afinogenova
-
Patent number: 11045551Abstract: Polymer-based antiseptic compositions are provided for treating wounds and/or for use in surgical operations, which form a film on the wound surface and have antiseptic, anesthetic and antitoxic effects. The compositions include polyvinylpyrrolidone with a weight average molecular weight in a range of 1,000,000 to 3,000,000 Da, one or more antiseptics, unithiol, dimethylsulfoxide, and one or more anesthetics. In addition, use of the compositions in a wound treatment, as well as methods for treating wounds using the compositions including the step of applying the composition to a wound surface are provided.Type: GrantFiled: December 14, 2017Date of Patent: June 29, 2021Assignee: MEDID INNOVATION DEVELOPMENT LTDInventors: Anna Gennadievna Afinogenova, Gennady Evgenievich Afinogenov, Tamaz Omarovich Manasherov, Svetlana Konstantinovna Matelo
-
Publication number: 20210008006Abstract: Colloidal antiseptic compositions for treating wounds and/or for use in surgical operations are provided. The compositions form an elastic air- and water-permeable biodegradable film on the wound surface and have antiseptic, hemostatic, anti-inflammatory, wound-healing, and especially anesthetic and antitoxic effects. The compositions include a collagen hydrolysate, one or more salts of alginic acid and one or more antiseptics, and additionally include unithiol and dimethylsulfoxide. The compositions may also optionally include one or more anesthetics.Type: ApplicationFiled: December 5, 2017Publication date: January 14, 2021Inventors: Gennady Evgenievich AFINOGENOV, Tamaz Omarovich MANASHEROV, Svetlana Konstantinovna MATELO, Anna Gennadievna AFINOGENOVA
-
Publication number: 20190381176Abstract: Polymer-based antiseptic compositions are provided for treating wounds and/or for use in surgical operations, which form a film on the wound surface and have antiseptic, anesthetic and antitoxic effects. The compositions include polyvinylpyrrolidone with a weight average molecular weight in a range of 1,000,000 to 3,000,000 Da, one or more antiseptics, unithiol, dimethylsulfoxide, and one or more anesthetics. In addition, use of the compositions in a wound treatment, as well as methods for treating wounds using the compositions including the step of applying the composition to a wound surface are provided.Type: ApplicationFiled: December 14, 2017Publication date: December 19, 2019Inventors: Anna Gennadievna AFINOGENOVA, Gennady Evgenievich AFINOGENOV, Tamaz Omarovich MANASHEROV, Svetlana Konstantinovna MATELO
-
Patent number: 9745337Abstract: The invention relates to the development of drugs intended for the prophylaxis and/or treatment of viral diseases caused, in particular, by herpes viruses. What are proposed are complex compounds of germanium having the general structural formula: Gex[AD][CA]y[AA]2 ??(1), where AD is a derivative of a nitrogenous base of the purine series that has antiviral activity and can be selected from guanine derivatives, such as acyclovir, valacyclovir, gancyclovir and pencyclovir, or from adenine derivatives, such as vidarabine; CA is a hydroxycarboxylic acid which can be selected from acids such as (but not limited to) citric acid, lactic acid and malic acid; AA is an amino acid which can be selected from various a-amino acids, such as arginine, gylcine, lysine and threonine, and where x=1-2, y=2-4 and z=0-2. Complex compounds of germanium have a high level of antiviral and immune-stimulating activity and are readily soluble in water.Type: GrantFiled: November 1, 2012Date of Patent: August 29, 2017Assignee: OBSCHESNO S OGRANICHENNOI OTVETSTVENNOSTYU “WDS FARMA”Inventors: Alexandr Dmitrievich Isaev, Igor Valerievich Ambrosov, Tamaz Omarovich Manasherov, Svetlana Konstantinovna Matelo
-
Patent number: 9597276Abstract: The invention solves the problem of the practical realization of an effective prophylactic composition which uses available and safe components and which can be recommended for preventing the growth of candidiasis of the skin and/or mucous membranes in humans in the following risk group: sufferers of diabetes mellitus, people with blood diseases, immune deficiency and other serious pathologies, patents after a course of hormone therapy, antibiotic treatment or chemotherapy, as well as for babies and pregnant women; and for people using tooth implants. The composition for the prophylaxis of candidiasis comprises active components, with the active components used being xylitol in a quantity of 0.3-20.0% by mass and sodium or potassium alginate or a mixture thereof in a quantity of 0.01-2.0% by mass, as well as inert components.Type: GrantFiled: June 3, 2015Date of Patent: March 21, 2017Assignee: OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'YU “WDS”Inventors: Tamaz Omarovich Manasherov, Svetlana Konstantinovna Matelo, Tat'yana Vladimirovna Kupets
-
Patent number: 9546188Abstract: The invention relates to complexes of germanium with amino acids and carboxylic acids of the general formula Ge[OH]a[AA]b[CA]c (I), where AA is an amino acid, CA is a carboxylic acid, a=0÷3, b=1÷3, c=0÷3, and 1?b+c?4, wherein AA and AC in the complex can be identical or different, and to a method for preparing same. The method consists in preparing an aqueous suspension of germanium dioxide, adding an amino acid and a carboxylic acid to the aqueous suspension of germanium oxide produced, heating the mixture produced with agitation at a temperature of 40-100° C. for 2-14 hours with subsequent filtering, removal of the water and production of a complex in solid form. The method makes it possible to prepare stable complexes with a controllable composition and a controllable ratio of germanium to amino acid and carboxylic acid which are stable in solid form and can be used in medicine.Type: GrantFiled: November 9, 2012Date of Patent: January 17, 2017Assignee: OBSCHESNO S OGRANICHENNOI OTVETSTVENNOSTYU “WDS FARMA”Inventors: Alexandr Dmitrievich Isaev, Tamaz Omarovich Manasherov, Igor Valerievich Ambrosov, Svetlana Konstantinovna Matelo
-
Publication number: 20150265517Abstract: The invention solves the problem of the practical realization of an effective prophylactic composition which uses available and safe components and which can be recommended for preventing the growth of candidiasis of the skin and/or mucous membranes in humans in the following risk group: sufferers of diabetes mellitus, people with blood diseases, immune deficiency and other serious pathologies, patents after a course of hormone therapy, antibiotic treatment or chemotherapy, as well as for babies and pregnant women; and for people using tooth implants. The composition for the prophylaxis of candidiasis comprises active components, with the active components used being xylitol in a quantity of 0.3-20.0% by mass and sodium or potassium alginate or a mixture thereof in a quantity of 0.01-2.0% by mass, as well as inert components.Type: ApplicationFiled: June 3, 2015Publication date: September 24, 2015Applicant: OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'YU "WDS"Inventors: Tamaz Omarovich Manasherov, Svetlana Konstantinovna Matelo, Tat'yana Vladimirovna Kupets
-
Publication number: 20150126726Abstract: The invention relates to the development of drugs intended for the prophylaxis and/or treatment of viral diseases caused, in particular, by herpes viruses. What are proposed are complex compounds of germanium having the general structural formula: Gex[AD][CA]y[AA]z??(I), where AD is a derivative of a nitrogenous base of the purine series that has antiviral activity and can be selected from guanine derivatives, such as acyclovir, valacyclovir, gancyclovir and pencyclovir, or from adenine derivatives, such as vidarabine; CA is a hydroxycarboxylic acid which can be selected from acids such as (but not limited to) citric acid, lactic acid and malic acid; AA is an amino acid which can be selected from various a-amino acids, such as arginine, glycine, lysine and threonine, and where x=1-2, y=2-4 and z=0-2. Complex compounds of germanium have a high level of antiviral and immune-stimulating activity and are readily soluble in water.Type: ApplicationFiled: November 1, 2012Publication date: May 7, 2015Applicant: OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU "WDS FARMA"Inventors: Alexandr Dmitrievich Isaev, Igor Valerievich Ambrosov, Tamaz Omarovich Manasherov, Svetlana Konstantinovna Matelo
-
Publication number: 20150011523Abstract: The invention relates to complexes of germanium with amino acids and carboxylic acids of the general formula Ge[OH]a[AA]b[CA]c (I), where AA is an amino acid, CA is a carboxylic acid, a=0-3, b=1-3, c=0-3, and 1<b+c?4, wherein AA and AC in the complex can be identical or different, and to a method for preparing same. The method preparing an aqueous suspension of germanium dioxide, adding an amino acid and a carboxylic acid to the aqueous suspension of germanium oxide produced, heating the mixture produced with agitation at a temperature of 40-100° C. for 2-14 hours with subsequent filtering, removal of the water and production of a complex in solid form. The method makes it possible to prepare stable complexes with a controllable composition and a control fable ratio of germanium to amino acid and carboxylic acid which are stable in solid form and can be used in medicine.Type: ApplicationFiled: November 9, 2012Publication date: January 8, 2015Inventors: Alexandr Dmitrievich Isaev, Tamaz Omarovich Manasherov, Igor Valerievich Ambrosov, Svetlana Konstantinovna Matelo
-
Patent number: 8460643Abstract: The invention relates to medicine, namely, to stomatology, in particular, to formulation for prophylaxis of oral cavity diseases. The formulation comprises: drinking water, glycerol, xylitol, silica, xanthan gum, methylparaben, propylparaben, titanium dioxide, perfume, bromelain, sodium saccharin, sodium lauryl sulfate or alkylamidobetain, calcium glycerophosphate, and magnesium chloride or glycerophosphate magnesium at following component ratio, % wt.: glycerol—20-25; xylitol—10-14; i 10 silica—22-26; xanthan gum—1.2-1.4; methylparaben—0.2-0.3; propylparaben—0.08-0.12; sodium saccharin—0.1-0.3; titanium dioxide—0.2-0.4; perfume—0.7-1.0; bromelain—0.1-0.7; sodium lauryl sulfate—1.2-1.4 or alkylamidobetain—1.2; calcium glycerophosphate—0.6-1.0; magnesium chloride—0.08-0.16 or magnesium glycerophosphate—0.16; and water—up to 100.Type: GrantFiled: November 25, 2005Date of Patent: June 11, 2013Assignee: Obschestvo S Organichennoi Otvetstvennostyu “WDS”Inventors: Tamaz Omarovich Manasherov, Svetlana Konstantinovna Matelo, Alexandr Vladimirovich Grosser
-
Publication number: 20130039866Abstract: The invention solves the problem of the practical realization of an effective prophylactic composition which uses available and safe components and which can be recommended for preventing the growth of candidiasis of the skin and/or mucous membranes in humans in the following risk group: sufferers of diabetes mellitus, people with blood diseases, immune deficiency and other serious pathologies, patents after a course of hormone therapy, antibiotic treatment or chemotherapy, as well as for babies and pregnant women; and for people using tooth implants. The composition for the prophylaxis of candidiasis comprises active components, with the active components used being xylitol in a quantity of 0.3-20.0% by mass and sodium or potassium alginate or a mixture thereof in a quantity of 0.01-2.0% by mass, as well as inert components.Type: ApplicationFiled: June 9, 2011Publication date: February 14, 2013Applicant: Obshchestvo S Ogranichennoj Otvetstvennostyu "WDS"Inventors: Tamaz Omarovich Manasherov, Svetlana Konstantinovna Matelo, Tat'yana Vladimirovna Kupets
-
Patent number: D785947Type: GrantFiled: January 13, 2015Date of Patent: May 9, 2017Assignee: OBSCHESTVO S OGRANICHENNOJ OTVETSTVENNOSTJU “EVROCOSMED-STUPINO”Inventors: Svetlana Konstantinovna Matelo, Tamaz Omarovich Manasherov
-
Patent number: D790862Type: GrantFiled: November 30, 2016Date of Patent: July 4, 2017Assignee: OBSCHESTVO S OGRANICHENNOJ OTVETSTVENNOSTJU “EVROCOSMED-STUPINO”Inventors: Svetlana Konstantinovna Matelo, Tamaz Omarovich Manasherov
-
Patent number: D794963Type: GrantFiled: January 9, 2015Date of Patent: August 22, 2017Assignee: OBSCHESTVO S OGRANICHENNOJ OTVETSTVENNOSTJU “EVROCOSMED-STUPINO”Inventors: Svetlana Konstantinovna Matelo, Tamaz Omarovich Manasherov
-
Patent number: D946901Type: GrantFiled: November 26, 2019Date of Patent: March 29, 2022Inventors: Svetlana Konstantinovna Matelo, Tamaz Omarovich Manasherov